Amplification of the int-2 oncogene was measured in a series of breast tumours and related to amplification of the c-myc and c-erbB-2 oncogenes, histopathological features and relapse-free and overall survival. int-2 was amplified in I I%, c-myc in 20% and c-erbB-2 in 27% of the tumours assessed. in
โฆ LIBER โฆ
Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival
โ Scribed by J. P. Geisler; H. E. Geisler; K. J. Manahan; G. A. Miller; M. C. Wiemann; Z. Zhou; W. Crabtree
- Book ID
- 110758763
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 87 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1048-891X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
int-2 Amplification in breast cancer: As
โ
J. A. Henry; C. Hennessy; D. L. Leveit; T. W. J. Len Nard; B. R. Westley; F. E.
๐
Article
๐
1993
๐
John Wiley and Sons
๐
French
โ 778 KB
Steroid hormone receptor immunohistochem
โ
Louis P. Pertschuk; Joseph G. Feldman; Dong S. Kim; Kamran Nayeri; Karen Byer Ei
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 762 KB
The assessment of proliferating cell nuc
โ
Mikiya Kitamoto; Toshio Nakanishi; Shinsuke Kira; Minoru Kawaguchi; Ryo Nakashio
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 631 KB
Nuclear size, shape, and density in endo
โ
J. Miller; J. P. Geisler; K. J. Manahan; H. E. Geisler; G. A. Miller; Z. Zhou; M
๐
Article
๐
2004
๐
John Wiley and Sons
๐
English
โ 103 KB
c-erbB-2 proto-oncogene expression and i
โ
S. Jain; M. Isabel Filipe; W. J. Gullick; Jacqueline Lineman; R. W. Morris
๐
Article
๐
1991
๐
John Wiley and Sons
๐
French
โ 468 KB
Apoptosis in colorectal carcinoma occurr
โ
Langlois, Neil E. I.; Lamb, Justin; Eremin, Oleg; Heys, Steven D.
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 306 KB
๐ 2 views
The aim of this study was to ascertain whether apoptotic counts have prognostic significance in colorectal cancer and if such counts are related to the expression of proteins implicated in cell cycle regulation. Material from a cohort of patients aged 45 years or less with colorectal carcinoma was r